Survey of lived experiences and challenges in hepatitis B management and treatment

Catherine Freeland,Charles Adjei,Jack Wallace,Su Wang,Jessica Hicks,Danjuma Adda,Cary James,Chari Cohen

DOI: https://doi.org/10.1186/s12889-024-18425-w

IF: 4.5

2024-04-02

BMC Public Health

Abstract:Abstract Almost 300 million people are living with chronic hepatitis B infection worldwide and most remain undiagnosed and at risk for liver cancer. In 2015 the World Health Organization (WHO) developed guidelines for the prevention, care, and treatment of persons with chronic hepatitis B and in early 2023 began to work on updating these guidelines. In March 2023, a self-administered, anonymous online survey was launched, aiming to identify patient preferences related to the clinical management of hepatitis B including current management, treatment, and care experiences, preferences regarding engagement with providers, and preferences related to simplifying hepatitis B care access. A sample of 560 individuals living with hepatitis B (self-identified as HBsAg positive) from 76 countries completed the survey. Key findings demonstrated that less than half (49%, N = 268) of participants regularly visited a doctor to check the health of their liver (every 6–12 months), with 37% of participants prescribed antiviral medication by a specialist (82%, N = 167) or general practitioner (13%, N = 26). Participants reported not being actively involved in care decision making with their providers (42%, N = 217), with an overwhelming majority wanting to participate in hepatitis B management and treatment choices (85%, N = 435). Participants provided qualitative and quantitative details using open-ended responses within the survey about challenges with medication affordability and receiving care from a knowledgeable provider. Overall findings demonstrated key gaps in care, management, and treatment access related to hepatitis B: identifying these gaps can be used to identify areas for improvement along the care continuum for viral hepatitis. The survey found a need for the comprehensive simplification of clinical management and health care services related to hepatitis B. A thematic analysis of the open-ended survey responses highlighted major overarching themes including the cost and access burdens associated with hepatitis B management and treatment, and challenges in finding knowledgeable providers. Results from this mixed methods survey were used to inform the WHO hepatitis B guidelines update. Efforts should continue to explore public health approaches to address barriers and facilitators to testing, care, and treatment for people with hepatitis B to improve awareness of hepatitis B and access, care, and treatment among patients and providers.

public, environmental & occupational health

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to solve several key problems that chronic hepatitis B patients encounter during medical management and treatment. Specifically, the main objectives of the study include:

1. **Identifying patient preferences and challenges**:
- Through an anonymous online survey, the study collected feedback from 560 chronic hepatitis B patients in 76 countries to understand their experiences and preferences in clinical management, treatment, and care.
- The survey specifically focused on the interactions between patients and healthcare providers, preferences for simplifying hepatitis B care, and the existing barriers in current management.

2. **Evaluating the compliance and acceptance of the existing WHO guidelines**:
- The study explored whether patients follow and accept the current World Health Organization (WHO) guidelines on hepatitis B treatment and monitoring. For example, only 49% of the respondents said that they regularly (every 6 - 12 months) visited a doctor to check their liver health.
- This indicates that many patients do not conduct regular monitoring and treatment according to the WHO - recommended standards.

3. **Revealing the major gaps in hepatitis B care**:
- The study found that hepatitis B patients face significant barriers in obtaining diagnosis, treatment, and care, especially in low - and middle - income countries (LMICs). These problems include high drug costs, a lack of experienced healthcare providers, and insufficient patient participation in treatment options.
- For example, 37% of the respondents were prescribed antiviral drugs, but many could not afford these drugs due to cost issues.

4. **Providing a basis for updating the WHO hepatitis B guidelines**:
- The study results will be used to guide the update of the WHO hepatitis B guidelines, especially in terms of making suggestions on how to simplify the clinical management of hepatitis B and improve patient participation.
- The survey results showed that 85% of patients hope to participate in hepatitis B management and treatment decision - making, which emphasizes the importance of patient participation.

5. **Exploring public health strategies**:
- The study also explored how to use public health measures to address the barriers in hepatitis B testing, care, and treatment, thereby increasing public awareness of hepatitis B and improving communication between patients and healthcare providers.
- Especially in Africa, where the hepatitis B burden is heavy but patients have limited access to care, targeted intervention measures are needed.

In general, this paper, through in - depth analysis of the real experiences and preferences of hepatitis B patients, reveals the existing problems in current hepatitis B care and provides valuable reference for future policy - making and clinical guidelines.